Figure 2From: A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malariaParasite clearance versus time (days) in the sickle cell disease (SCD) and non-SCD (HbAA) groups. SCD-mal + = sickle cell disease subjects with acute malaria group; Non-SCD (HbAA)-mal + = non-SCD subjects with acute malaria group.Back to article page